LD Micro Invitational
June 6-7, 2017
Luxe Hotel Sunset Boulevard (Los Angeles)
The two-day, 7th annual LD Micro Invitational will feature company presentations from nearly 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. On the 7th, companies across three unique themes will present: Reg A+, "The Best of Buy-Side," and "Show Me the Money," which focuses solely on names with large insider buying over the past year. For more information on LD Micro, visit www.ldmicro.com
S&W Seed Company (SANW)
S&W Seed Company (NASDAQ: SANW) is a global agricultural company aiming to be the world's preferred proprietary seed company and supplier of a range of forage and specialty crop products that support the growing global demand for animal proteins and healthier consumer diets. The company is a global leader in alfalfa seed, with significant research and development, production and distribution capabilities. S&W's capabilities span the world's alfalfa seed production regions, with operations in the Western United States, including the San Joaquin and Imperial Valleys of California, Australia, and Canada. S&W also provides hybrid sorghum and sunflower, and is utilizing its research and breeding expertise to develop and produce stevia, the all-natural, zero calorie sweetener for the food and beverage industry. For more information, visit the company's website at www.swseedco.com.
NAPCO Security Technologies (NSSC)
NAPCO Security Technologies (NASDAQ: NSSC) manufactures and sells security products and software worldwide. The company offers access control systems, door security products, intrusion and fire alarm systems, and video surveillance systems for commercial, residential, institutional, industrial and governmental applications. Its access control systems include various types of identification readers, control panels, PC-based computers, and electronically activated door-locking devices; and door locking devices, such as microprocessor-based electronic door locks with push button, card readers and bio-metric operation, door alarms, mechanical door locks, and simple dead bolt locks. For more information, visit the company's website at www.napcosecurity.com.
Alimera Sciences (ALIM)
Alimera Sciences (NASDAQ: ALIM), founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. The company's commitment to retina specialists and their patients is manifest in its product and development portfolio designed to treat early and late stage diseases. For more information, visit the company's website at www.alimerasciences.com.
Helix TCS (OTC: HLIX) is focused on providing clients in the cannabis industry with the most powerful and cutting-edge integrated operating environments in the market, helping them to better manage and mitigate risk while they focus on their core business. The company accomplishes these goals through a unique combination of business, logistics, risk-management, and investment skills, delivered through a proprietary software suite and partnership platform. For more information, visit the company's website at www.helixtcs.com.
Digiliti Money (DGLT)
Digiliti Money (NASDAQ: DGLT) provides cloud-based software-as-a-service (SaaS) financial technology (fintech) solutions to the financial services industry in the United States. It provides Select Mobile Money, a prepaid mobile money platform that links various mobile banking features with a prepaid debit card issued by financial institutions or alternative financial service (AFS) providers. Digiliti Money also offers RDC product, including Select Business Merchant Capture, which provides the ability to scan and deposit checks from PC, Mac desktop computer, or mobile device. For more information, visit the company's website at www.cachetfinancial.com.
ParkerVision (NASDAQ: PRKR) designs, develops and markets proprietary radio frequency (RF) technologies for use in wireless communication products in the United States. Its technology applies to transmit and receive functions of transmitters, receivers, and transceivers, as well as other related RF communications functions. The transmit portion of the technology, Direct2Power, enables the transformation of a baseband data signal to an RF carrier waveform, at the desired power output level, in a single unified operation; and the receiver portion of the technology, Direct2Data, enables the direct conversion of an RF carrier to a baseband data signal, as well as enables the direct conversion of a baseband signal to a modulated RF carrier signal. For more information, visit the company's website at www.parkervision.com.
Jerrick Media Holdings (JMDA)
Jerrick Media Holdings (OTCQB: JMDA) is a digital media content publishing house. Vocal, a proprietary technology and content distribution platform, is central to the company's unique capabilities and is programmed to deliver a robust long-form, digital publishing platform organized into highly engaged niche-communities that are capable of hosting all types of rich media content. Vocal creates an unmatched user experience by maximizing scalability, speed, simplicity and adaptability and is algorithmically designed to bridge media-rich long-form creative content with effective monetization. A dedicated team and culture oversees each niche-community site, with a primary focus on revenue conversion of all published material through digital arbitrage. For more information, visit the company's website at www.jerrick.media.
root9B Holdings, Inc. (RTNB)
root9B Holdings, Inc. (Nasdaq: RTNB) provides cybersecurity and regulatory risk mitigation services through its wholly owned subsidiaries: root9B, Business Advisory Services, and IPSA International Services, Inc. The company delivers results that improve productivity, mitigate risk and maximize profits. Its clients range in size from Fortune 100 companies to mid-sized and owner-managed businesses across a broad range of industries including local, state and government agencies. For more information, visit the company's website at www.root9bholdings.com.
BioVie (OTC: BIVI) is a development-stage biotech that discovers, develops and commercializes various drug therapies in the Unites States. The company focuses on the commercialization of BIV201 for the treatment of ascites due to liver cirrhosis. It also discovers and develops broad spectrum antibiotics for gram-negative and gram-positive bacterial infections. BioVie was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie was founded in 2013 and is based in Beverly, Massachusetts. For more information, visit the company's website at www.biovieinc.com.
Profire Energy (PFIE)
Profire Energy (NASDAQ: PFIE) is an oilfield technology company that develops and sells combustion management technologies for the oil and gas. It also assists energy production companies in production and transportation of oil and natural gas. The company offers burner-management systems to ignite, monitor and manage the burner flames used in oilfield vessels as well as related products such as valves and fuel trains, air-plates, solar packages and flare stack igniter and nozzles. It also provides chemical-management systems to monitor and manage chemical-injection processes to ensure that optimal levels of chemicals are injected. For more information, visit the company's website at www.profireenergy.com.
MRI Interventions (MRIC)
MRI Interventions (OTCQB: MRIC) is a medical device company that develops and commercializes platforms for performing minimally invasive surgical procedures in the brain. The ClearPoint Neuro Navigation System is a neuro intervention system that is designed for placing catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, and for performing biopsies in the brain. Additionally, the ClearPoint Neuro Navigation System utilizes a hospital's existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. ClearPoint has received 510(k) clearance and is CE marked. For more information, visit the company's website at www.mriinterventions.com.
Enservco (NYSE: ENSV) provides oil field services to the onshore oil and natural gas industry in the United States. The company operates through Well Enhancement Services, Water Transfer Services, Water Hauling Services, and Construction Services segments. It offers frac water heating, hot oiling, pressure testing, acidizing, water transfer, bacteria and scale treatment, freshwater and saltwater hauling, fluid disposal, frac tank rental, well site construction, and other general oil field services. The company owns and operates a fleet of approximately 650 specialized trucks, trailers, frac tanks, and other well-site related equipment. For more information, visit the company's website at www.enservco.com.
MRV Communications (MRVC)
MRV Communications (NASDAQ: MRVC) designs, manufactures, distributes and services optical networking solutions and Internet infrastructure products worldwide. It offers optical transport, packet/carrier Ethernet, network management, and infrastructure management products and services. The company also provides out-of-band network equipment, as well as designs and manufactures fiber optic modules for the fiber-optic communications industry. Its portfolio of packet and optical solutions enable the access, aggregation, transport and management of various communications traffic for fixed line, cable, content delivery, cloud-based and mobile communications networks. For more information, visit the company's website at www.mrv.com.
ATA (NASDAQ: ATA) is a provider of computer-based testing services in China. The company offers services for the creation and delivery of computer-based tests utilizing its test delivery platform, testing technologies and testing services in China. Its computer-based testing services are used for licensure and certification tests in various industries, including information technology (IT) services, banking, securities, teaching and insurance. The company's computer-based testing services clients include professional associations, Chinese governmental agencies and state-owned enterprises. The company's test center network includes approximately 3,035 test centers located throughout China. Its network allows its clients to administer computer-based and paper-based tests. The company has delivered approximately 88.1 million tests, including approximately 11.8 million free tests for business development purposes. For more information, visit the company's website at www.atai.net.cn.
Xebec Adsorption Inc. (XBC)
Xebec Adsorption Inc. (OTC: XBC) provides gas purification and filtration solutions for the natural gas, field gas, biogas, helium and hydrogen markets in Canada and internationally. The company designs, develops, builds, sells and services a range of pressure swing adsorption and membrane gas purification systems for biogas purification under the BGX Solutions brand; natural gas dehydration and conditioning units for natural gas vehicle refueling stations and for natural gas upgrading under the NGX Solutions brand; hydrogen purification pressure swing adsorption systems under the H2X Solutions brand; and helium purification systems under the SGX Solutions brand. For more information, visit the company's website at www.xebecinc.com.
Remark Holdings (MARK)
Remark Holdings (NASDAQ: MARK) owns, operates and acquires digital media properties across multiple verticals that deliver content worldwide. The company leverages its digital media assets to target the Millennial demographic, which provides it with access to markets. It operates KanKan, a social media application and data intelligence platform, which aggregates content and consumer-shopping data across social media platforms; Vegas.com that offers users the ability to book lodging, air travel, show tickets, and tours; and Roomlia, a mobile hotel-booking application. The company also operates Banks.com website, which provides content for young adults that shares stories of financial success and failure. For more information, visit the company's website at www.remarkmedia.com.
Differential Brands Group (DFBG)
Differential Brands Group (NASDAQ: DFBG) engages in the design, development, sale and licensing of apparel products and accessories under the Robert Graham brand name worldwide. It operates through Wholesale and Consumer Direct segments. The company's product line includes men's sport shirts, denim jeans, pants, shorts, sweaters, knits, T-shirts, sportscoats, outerwear and swimwear; shoes, belts, small leather goods, dress shirts, neckwear, tailored clothing, headwear, eye and sun glasses, jewelry, hosiery, underwear, loungewear and fragrances for men that are produced through third parties under various license agreements; and women's apparel. For more information, visit the company's website at www.differentialbrandsgroup.com.
VolitionRx Limited (VNRX)
VolitionRx Limited (NYSE: VNRX) is a life sciences company that focuses on developing blood-based tests to diagnose a range of cancers. The company is involved in the development of epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRx develops blood assays in the Nu.Q-X family to detect nucleosomes containing specific nucleotides; and blood assays in the Nu.Q-V family to detect nucleosomes containing specific histone variants. The company also develops blood assays in the Nu.Q-M family to detect nucleosomes containing modified histones that are proteins for packaging and ordering DNA into nucleosomes. For more information, visit the company's website at www.volitionrx.com.
Marrone Bio Innovations (MBII)
Marrone Bio Innovations (NASDAQ: MBII) aims to lead the movement to a more sustainable world by playing a key role in the discovery, development and promotion of biological products for pest management and plant health. The company currently markets five products for the agriculture market (Regalia®, Grandevo®, Venerate®, Majestene® and Haven™) and distributes Bio-tam 2.0® for Isagro USA in the western United States. Additionally, Marrone markets Zequanox® for the management of invasive mussels in water markets. Together, these effective and environmentally responsible solutions help the company's customers operate more sustainably while simultaneously improving plant health and increasing crop yields. For more information, visit www.marronebio.com.
ENDRA Life Sciences (NDRAU)
ENDRA Life Sciences (NASDAQ: NDRAU) is engaged in the development of photo- and thermo-acoustic medical technologies that bring new capabilities to existing ultrasound systems, helping global medical researchers screen and modify disease models with high image quality and volume scanning speed. ENDRA's global installed base consists of leading institutions that use the Nexus-128 system, which is the only commercially available 3D imaging system for imaging anatomy, physiology and labeled molecular targets. The company's thermo-acoustic technology is being developed to enable clinicians to use existing ultrasound equipment to visualize tissue function and composition and to monitor various therapeutic interventions at the point of care. For more information, visit the company's website at www.endrainc.com.
Diffusion Pharmaceuticals (DFFN)
Diffusion Pharmaceuticals (NASDAQ: DFFN) is a clinical-stage biotechnology company that focuses on developing products for ophthalmology, oncology and dermatology. Its lead product candidate is transcrocetinate sodium, which is in phase I/II clinical trials for re- oxygenating treatment-resistant tissue, and making the cancer cells more susceptible to the therapeutic effects of radiation therapy and chemotherapy. The company is also developing RES-529, a novel PI3K/Akt/mTOR pathway inhibitor, which has completed two phase I clinical trials for the treatment of macular degeneration, and is in pre-clinical development in oncology applications primarily glioblastoma multi-forme. For more information, visit the company's website at www.diffusionpharma.com.
Apollo Medical Holdings (AMEH)
Apollo Medical Holdings (OTC: AMEH) is an integrated population health management company headquartered in Glendale, California. ApolloMed is dedicated to providing excellent multi-disciplinary care in the community it serves and is engaged in addressing the healthcare needs of patients by leveraging an integrated healthcare delivery platform. This platform consists of ApolloMed Hospitalists, ApolloMed ACO (accountable care organization), APA ACO (next-generation ACO), Maverick Medical Group (independent physician association), Apollo Care Connect, and Apollo Palliative Services (hospice/palliative care and home health services). The company's aim is improving medical outcomes through high-quality, cost-effective care. For more information, visit the company's website at www.apollomed.net.
The Joint (JYNT)
The Joint (NASDAQ: JYNT) develops, owns, operates, franchises, supports and manages chiropractic clinics in the United States. The Joint is reinventing chiropractic care by making quality healthcare affordable for patients seeking pain relief and ongoing wellness. Its membership plans and packages eliminate the need for insurance, and our no-appointment policy, convenient hours and locations make care more accessible. As of July 20, 2016, it operated and franchised approximately 340 clinics. The company was founded in 2010 and is headquartered in Scottsdale, Arizona. For more information, visit the company's website at www.thejoint.com.
Digital Power (DPW)
Digital Power (NYSE: DPW) is focused on designing, manufacturing and selling high-grade customized and off-the-shelf power system solutions. Based in Fremont, California, the company offers products that are used in the most demanding communications, industrial, medical and military applications, meeting customer demand for high-density, high-efficiency and ruggedized power solutions. Digital Power's wholly owned subsidiary, Digital Power Limited, does business as Gresham Power Electronics and is based in Salisbury, UK. For more information, visit the company's website at www.digipwr.com.
FitLife Brands (FTLF)
FitLife Brands (OTCBB: FTLF) is an international provider of innovative, proprietary nutritional supplements for health-conscious consumers. The company markets more than 80 dietary supplements under the brand names NDS Nutrition Products, PMD, SirenLabs, CoreActive, Metis Nutrition, iSatori, Energize and BioGenetic Laboraties. FitLife's supplements are created to promote sports nutrition, enhanced performance, weight loss and general health and are chiefly marketed through domestic and international GNC franchise locations. For more information, visit the company's website at www.fitlifebrands.com.
TrovaGene (NASDAQ: TROV) is a molecular diagnostic company that focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It offers Precision Cancer Monitoring (PCM) platform, a cell-free molecular diagnostic platform that provides cancer monitoring by tracking and quantifying levels of cell-free DNA from either urine or blood samples. For more information, visit the company's website at www.trovagene.com.
GWG Holdings (GWGH)
GWG Holdings (NASDAQ: GWGH) is a financial purchaser of life insurance assets in the secondary market. The company creates opportunities for consumers owning life insurance to obtain value for their policies as compared to the traditional options offered by insurance companies. The company also creates opportunities for investors to participate in alternative asset classes, such as life insurance, not correlated to traditional financial markets. The company generally purchases life insurance assets directly from policy owners having purchased their life insurance in the primary market. For more information, visit the company's website at www.gwglife.com.
OptimizeRx (OTCQB: OPRX) provides technology solutions for the health care industry, offering pharmaceutical manufacturers a direct to consumer and/or direct to physician channels for communicating and promoting their products. Its products include SampleMD, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies. The company also offers OPTIMIZERx.com, a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs; and OPTIMIZEHR, which provides consulting services to pharmaceutical manufacturers for identifying, formulating, and implementing eRx media strategies for promoting their products. For more information, visit the company's website at www.optimizerx.com.
BIOLASE (NASDAQ: BIOL) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. It's Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed. For more information, visit the company's website at www.biolase.com.
Veru Healthcare (FHCO)
Veru Healthcare (NASDAQ: FHCO) is a medical therapeutics company, develops, manufactures, and markets consumer health care products. The company's pharmaceuticals product portfolio includes the Tamsulosin delayed release sachet that is under bioequivalence study for the treatment of benign prostatic hyperplasia; MSS-722, a fixed ratio of trans- and cis-clomiphene citrate isomers, which is under the phase II clinical trial to treat male infertility caused by testicular dysfunction; APP-944, a zuclomiphene citrate that is under the phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and APP-111, an oral tubulin targeting chemotherapy, which is under the preclinical study to treat metastatic prostate, breast, and ovarian cancers, as well as APP-111/112 oral agents that target colchicine binding site of tubulin for the treatment of gout and familial Mediterranean fever. For more information, visit the company's website at www.veruhealthcare.com.
Intevac (NASDAQ: IVAC) provides vacuum deposition equipment for various thin-film applications, and digital night-vision technologies and products to the defense industry in the United States, Asia and Europe. It operates through two segments, Thin-film Equipment and Photonics. The Thin-film Equipment segment designs, manufactures, markets and services disk sputtering systems, etch and deposition systems, and disk lubrication systems; and offers upgrades, and spares and consumables, as well as provides process and applications support, customer training, installation, start-up assistance, and post-installation service support services. For more information, visit the company's website at www.intevac.com.
Barnwell Industries (BRN)
Barnwell Industries (NYSE: BRN) is engaged in various lines of business, such as acquiring, developing, producing and selling oil and natural gas in Canada; investing in land interests in Hawaii; drilling wells, and installing and repairing water pumping systems in Hawaii, and developing homes for sale in Hawaii. The Company's segments include Oil and Natural Gas Segment; Land Investment Segment; Contract Drilling Segment, and Residential Real Estate Segment. The Company's investments in oil and natural gas properties are located in Canada. It holds interests in Kaupulehu Developments, a Hawaii general partnership. Its subsidiary, Water Resources International, Inc., drills water and water monitoring wells of varying depths in Hawaii. For more information, visit the company's website at www.brninc.com.
Table Trac (TBTC)
Table Trac (OTC: TBTC) develops and sells Table Trac, a proprietary information and management system that automates and monitors the operations of casino table games in the United States. The company also offers Casino Trac, a casino management system. Its Table Trac system adds functionality to related casino system modules for guest rewards and loyalty club, marketing analysis, guest service, promotions, administration/management, vault/cage management, and audit/accounting tasks. In addition, Table Trac provides system sales services comprising installation, custom casino system configuration, and training, as well as technical support services to casinos. For more information, visit the company's website at www.tabletrac.com.
Intevac (NASDAQ: IVAC) was founded in 1991 and has two businesses: Thin-film Equipment and Photonics. Through its Thin-film Equipment business, Intevac provides design and development of high-productivity, thin-film processing systems. Its production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets. The company's Photonics business develops advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. Intevac is the provider of integrated digital imaging systems for most U.S. military night vision programs. For more information, visit the company's website at www.intevac.com.
IEH (OTC: IEHC) designs, develops and manufactures printed circuit connectors for high-performance applications. Its products include standard printed circuit board connectors, circular connectors, connector cable assemblies, high density connectors, and plastic circular connectors, which are used as basic components of larger assemblies of finished goods. The company markets its products directly to original equipment manufacturers, as well as through authorized representatives and distributors primarily to government, military, aerospace, medical, automotive, industrial, test equipment and commercial electronics markets. It markets its products in the United States, Canada, Israel, India, various Pacific Rim countries, South Korea, and the European Union. For more information, visit the company's website at www.iehcorp.com.
Lantronix (NASDAQ: LTRX) is a worldwide provider of secure data access and management solutions for Internet of Things (IoT) and information technology (IT) assets. Lantronix's mission is to be a leader in supplying IoT gateways that allow companies to significantly simplify the creation, deployment and management of IoT projects while also providing secure access to data for applications and people. Lantronix's connectivity solutions are deployed in millions of machines that serve a broad array of industries, including data center, security, medical, transportation, industrial, retail, financial, environmental and government. For more information, visit the company's website at www.lantronix.com.
OncoSec Medical (ONCS)
OncoSec Medical (NASDAQ: ONCS) is a biotech company developing DNA-based intratumoral immunotherapies with an investigational technology, ImmunoPulse®, for the treatment of cancer. ImmunoPulse® is designed to enhance the local delivery and uptake of DNA-based immune-targeting agents. In phase I and II clinical trials, ImmunoPulse® IL-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various solid tumors as well as the potential to initiate a systemic immune response. OncoSec's lead program, ImmunoPulse® IL-12, is currently in clinical development for several indications, including metastatic melanoma, and triple-negative breast cancer. In addition to ImmunoPulse® IL-12, the Company is also identifying and developing new immune-targeting agents for use with the ImmunoPulse® platform. For more information, visit the company's website at www.oncosec.com.
Healthier Choices Management (HCMC)
Healthier Choices Management (OTC: HCMC) is a holding company dedicated to providing consumers with healthier daily choices when it comes to nutrition and other lifestyle alternatives. One segment of the company's business is its natural and organic grocery operations in Ft. Myers, Florida, and the other is a U.S.-based retailer of vaporizers and e-liquids. Healthier Choices Management sells its products directly to consumers through company-owned brick-and-mortar retail locations that operate under the Ada's Natural Organic and The Vape Store brands. For more information, visit the company's website at www.healthiercmc.com.
Invo Bioscience (IVOB)
Invo Bioscience (OTC: IVOB) is a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Its INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. The company's lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). For more information, visit the company's website at www.invobioscience.com.
Therapix Biosciences (TRPX)
Therapix Biosciences (NASDAQ: TRPX) is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in two internal drug development programs based on repurposing an FDA-approved synthetic cannabinoid (dronabinol): THX-TS01 targets to the treatment of Tourette's syndrome; and THX-ULD01 targets the high-value and under-served market of mild cognitive impairments. For more information, visit the company's website at www.therapixbio.com.